APA aipamena

Nanjo, S., Ebi, H., Arai, S., Takeuchi, S., Yamada, T., Mochizuki, S., . . . Yano, S. (2015). High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cells. Oncotarget.

Chicago Style aipamena

Nanjo, Shigeki, et al. "High Efficacy of Third Generation EGFR Inhibitor AZD9291 in a Leptomeningeal Carcinomatosis Model With EGFR-mutant Lung Cancer Cells." Oncotarget 2015.

MLA aipamena

Nanjo, Shigeki, et al. "High Efficacy of Third Generation EGFR Inhibitor AZD9291 in a Leptomeningeal Carcinomatosis Model With EGFR-mutant Lung Cancer Cells." Oncotarget 2015.